Individual #00235339

ID_report Fam1PatII1
Reference PubMed: Waters 2019
Remarks 2-generation pedigree (1 affected male), unaffected heterozygous mother
Gender M
Consanguinity -
Country Canada
Population French-Canadian
Age at death >11y (later than 11 years)
VIP -
Data_av yes
Treatment -
Panel size 1
Diseases HSD10MD, SPG4
Owner name Sebastien Levesque
Database submission license No license selected
Created by Sebastien Levesque
Date created 2019-05-22 19:11:54 +02:00 (CEST)
Date last edited 2020-06-05 18:45:31 +02:00 (CEST)


Phenotypes

HSD10 Mi disease (HSD10MD)   Add phenotype for this disease

AscendingPhenotype ID     

Diagnosis/Initial     

Inheritance     

Age/Examination     

Diagnosis/Definite     

Age/Onset     

Phenotype/Onset     

Phenotype details     

Enzyme/Activity     

Protein     

Age/Diagnosis     

Owner     
0000175601 - Familial, X-linked - HSD10D 00y06m progressive spastic quadriplegia (HP:0002478), motor delay (HP:0001270) elevation of 2-methyl-3-hydroxybutyrate (94; normal <18 mmol/mol creatinine) and tiglylglycine (74; normal <5 mmol/mol creatinine) - - 06y Sebastien Levesque

paraplegia, spastic, autosomal dominant, type 4 (SPG4) (SPG4)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000230170 progressive spastic quadriplegia (HP:0002478), motor delay (HP:0001270), dysarthria (HP:0001260) - SPG4 Isolated (sporadic) - - 00y06m progressive spastic quadriplegia (HP:0002478), motor delay (HP:0001270) - Johan den Dunnen



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000236444 DNA SEQ-NG - WES - 2 Sebastien Levesque



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
2 Unknown +?/. - likely pathogenic (dominant) g.32362009A>G g.32136940A>G - - SPAST_000095 - PubMed: Waters 2019 - - De novo - - - - - Johan den Dunnen SPAST - - - - - NM_014946.3:c.1385A>G - r.(?) p.(Lys462Arg) - - - - - - - - - - - - - -
X Maternal (confirmed) ?/. - VUS g.53459058G>C g.53432110G>C - - HSD17B10_000005 associated with elevation of urinary 2-methyl-3-hydroxybutyric acid and tiglylglycine, but no clear neurological phenotype that is not explained by a de novo SPAST variant - 11443 - Germline - - - - - Sebastien Levesque HSD17B10 - - - - - NM_004493.2:c.364C>G - r.(?) p.(Leu122Val) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.